Stereotactic body radiotherapy for early stage non-small cell lung cancer

  • Publication
    Online – June 2017

    This guideline looks at four key questions regarding SBRT inch allenging clinical scenarios in early-stage NSCLC. It first offers recommendations on application of SBRT to operable patients. Next, the document explores appropriate use of SBRT in tumors that are centrally located, large, multifocal or unbiopsied, as well as individual tailoring of SBRT in “high-risk” clinical scenarios. Finally, it addresses SBRT as salvage therapy after recurrence.

    Read the executive summary
    Read full guideline

    Quick Reference

    • SBRT as alternative to surgery
    • SBRT techniques for medically inoperable patients


    Comparison of the Effectiveness of Radiofrequency Ablation with SBRT in Inoperable Stage I NSCLC
    ASTRO’s SBRT Model Policy

    Author Society
    American Society for Radiation Oncology

    Previous version

    American Society of Clinical Oncology
    The Royal Australian and New Zealand College of Radiologists
    European Society for Radiotherapy and Oncology

  • Disclaimer

    ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited.